|
1
|
Jia WH, Luo XY, Feng BJ, Ruan HL, Bei JX,
Liu WS, Qin HD, Feng QS, Chen LZ, Yao SY, et al: Traditional
Cantonese diet and nasopharyngeal carcinoma risk: A large-scale
case-control study in Guangdong, China. BMC Cancer. 10:4462010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu FH, Xiong D, Xu YF, Cao SM, Xue WQ, Qin
HD, Liu WS, Cao JY, Zhang Y, Feng QS, et al: An epidemiological and
molecular study of the relationship between smoking, risk of
nasopharyngeal carcinoma, and Epstein-Barr virus activation. J Natl
Cancer Inst. 104:1396–1410. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yoshizaki T, Ito M, Murono S, Wakisaka N,
Kondo S and Endo K: Current understanding and management of
nasopharyngeal carcinoma. Auris Nasus Larynx. 39:137–144. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu
LZ, Sun Y, Lin AH, Liu MZ and Ma J: How does intensity-modulated
radiotherapy versus conventional two-dimensional radiotherapy
influence the treatment results in nasopharyngeal carcinoma
patients? Int J Radiat Oncol Biol Phys. 80:661–668. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bandres E, Agirre X, Ramirez N, Zarate R
and Garcia-Foncillas J: MicroRNAs as cancer players: Potential
clinical and biological effects. DNA Cell Biol. 26:273–282. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peng XH, Huang HR, Lu J, Liu X, Zhao FP,
Zhang B, Lin SX, Wang L, Chen HH, Xu X, et al: MiR-124 suppresses
tumor growth and metastasis by targeting Foxq1 in nasopharyngeal
carcinoma. Mol Cancer. 13:1862014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu N, Tang LL, Sun Y, Cui RX, Wang HY,
Huang BJ, He QM, Jiang W and Ma J: MiR-29c suppresses invasion and
metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Cancer
Lett. 329:181–188. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rietzschel N, Pierik AJ, Bill E, Lill R
and Mühlenhoff U: The basic leucine zipper stress response
regulator Yap5 senses high-iron conditions by coordination of
[2Fe-2S] clusters. Mol Cell Biol. 35:370–378. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He Q, Ren X, Chen J, Li Y, Tang X, Wen X,
Yang X, Zhang J, Wang Y, Ma J, et al: miR-16 targets fibroblast
growth factor 2 to inhibit NPC cell proliferation and invasion via
PI3K/AKT and MAPK signaling pathways. Oncotarget. 7:3047–3058.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen X, Chen S, Xiu YL, Sun KX, Zong ZH
and Zhao Y: RhoC is a major target of microRNA-93-5P in epithelial
ovarian carcinoma tumorigenesis and progression. Mol Cancer.
14:312015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ke ZP, Xu P, Shi Y and Gao AM: MicroRNA-93
inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by
targeting PTEN. Oncotarget. 7:28796–28805. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xiao WF, Li YS, Lou W, Cai T, Zhang S, Hu
XY, Zhang XW and Luo W: MicroRNA-93-5p may participate in the
formation of morphine tolerance in bone cancer pain mouse model by
targeting Smad5. Oncotarget. 7:52104–52114. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gartel AL and Radhakrishnan SK: Lost in
transcription: p21 repression, mechanisms, and consequences. Cancer
Res. 65:3980–3985. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rodriguez R and Meuth M: Chk1 and p21
cooperate to prevent apoptosis during DNA replication fork stress.
Mol Biol Cell. 17:402–412. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiong Y, Zhang H and Beach D: D type
cyclins associate with multiple protein kinases and the DNA
replication and repair factor PCNA. Cell. 71:505–514. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ho SL, Chan HM, Ha AW, Wong RN and Li HW:
Direct quantification of circulating miRNAs in different stages of
nasopharyngeal cancerous serum samples in single molecule level
with total internal reflection fluorescence microscopy. Anal Chem.
86:9880–9886. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bruce JP, Yip K, Bratman SV, Ito E and Liu
FF: Nasopharyngeal Cancer: Molecular Landscape. J Clin Oncol.
33:3346–3355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang HY, Yan LX, Shao Q, Fu S, Zhang ZC,
Ye W, Zeng YX and Shao JY: Profiling plasma microRNA in
nasopharyngeal carcinoma with deep sequencing. Clin Chem.
60:773–782. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang L, Huang J, Li L, Chen Y, Chen X,
Zhao X and Yang D: MicroRNA-93 promotes ovarian granulosa cells
proliferation through targeting CDKN1A in polycystic ovarian
syndrome. J Clin Endocrinol Metab. 100:E729–E738. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu J, Wang H, Wang Y, Li Z, Pan Y, Liu Q,
Yang M and Wang J: Repression of the miR-93-enhanced sensitivity of
bladder carcinoma to chemotherapy involves the regulation of LASS2.
Onco Targets Ther. 9:1813–1822. 2016.PubMed/NCBI
|
|
24
|
Liang H, Wang F, Chu D, Zhang W, Liao Z,
Fu Z, Yan X, Zhu H, Guo W, Zhang Y, et al: miR-93 functions as an
oncomiR for the downregulation of PDCD4 in gastric carcinoma. Sci
Rep. 6:237722016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qu MH, Han C, Srivastava AK, Cui T, Zou N,
Gao ZQ and Wang QE: miR-93 promotes TGF-β-induced
epithelial-to-mesenchymal transition through downregulation of
NEDD4L in lung cancer cells. Tumour Biol. 37:5645–5651. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu YF, Mao YP, Li YQ, Ren XY, He QM, Tang
XR, Sun Y, Liu N and Ma J: MicroRNA-93 promotes cell growth and
invasion in nasopharyngeal carcinoma by targeting disabled
homolog-2. Cancer Lett. 363:146–155. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Wang F, Xu J, Wang X, Ye F and
Xie X: Micro ribonucleic acid-93 promotes oncogenesis of cervical
cancer by targeting RAB11 family interacting protein 1. J Obstet
Gynaecol Res. 42:1168–1179. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cioffi M, Vallespinos-Serrano M, Trabulo
SM, Fernandez-Marcos PJ, Firment AN, Vazquez BN, Vieira CR, Mulero
F, Camara JA, Cronin UP, et al: MiR-93 controls adiposity via
inhibition of Sirt7 and Tbx3. Cell R. 12:1594–1605. 2015.
View Article : Google Scholar
|
|
29
|
Yi C, Wang Q, Wang L, Huang Y, Li L, Liu
L, Zhou X, Xie G, Kang T, Wang H, et al: MiR-663, a microRNA
targeting p21WAF1/CIP1, promotes the proliferation and
tumorigenesis of nasopharyngeal carcinoma. Oncogene. 31:4421–4433.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ivanovska I, Ball AS, Diaz RL, Magnus JF,
Kibukawa M, Schelter JM, Kobayashi SV, Lim L, Burchard J, Jackson
AL, et al: MicroRNAs in the miR-106b family regulate p21/CDKN1A and
promote cell cycle progression. Mol Cell Biol. 28:2167–2174. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
le Sage C, Nagel R, Egan DA, Schrier M,
Mesman E, Mangiola A, Anile C, Maira G, Mercatelli N, Ciafrè SA, et
al: Regulation of the p27Kip1 tumor suppressor by miR-221 and
miR-222 promotes cancer cell proliferation. EMBO J. 26:3699–3708.
2007. View Article : Google Scholar : PubMed/NCBI
|
